HTB homepage • Conference reports • Articles by subject • Subscribe October 2006 Contents Editorial Volume 7 Number 10 October 2006 New i-Base Book: Why we must provide HIV treatment information Conference reports 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 23-26 September 2006, San Francisco The role of the metabolic syndrome in HIV Effect of lifestyle modification on risk factors for cardiovascular disease and metabolic syndrome Pioglitazone reduces peripheral lipoatrophy and improves adipokines without reducing visceral fat Leptin reduces visceral abdominal tissue (VAT) without reducing limb fat Adipose tissue morphology improved after treatment discontinuation Incidence of lipodystrophy in Rwanda 46th Interscience Conference on Antiretroviral Agents and Chemotherapy (ICAAC), 27-30 September 2006, San Francisco MK-0518 demonstrates potent efficacy in patients with triple-class resistant virus: 24 week results Lipid profile of integrase inhibitor MK-0518: 24 week results compared to efavirenz in treatment naive patients Cell studies predict cross-resistance among integrase inhibitors HIV may use different coreceptors in blood and brain Critical interactions between darunavir (TMC114), lopinavir, Viagra, and oral contraceptives NRTI elvucitabine active against HIV in a 7-day monotherapy study Efavirenz/tenofovir fails as 2-drug maintenance regimen Nucleoside inhibitor MK-0608 mediates suppression of HCV replication for >30 days in chronically infected chimpanzees Report from the 10th Annual UK Resistance Meeting, 21 September 2006, London Further reports from XVI International AIDS Conference, 13-18 August 2006, Toronto, Canada Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV positive women in Lusaka, Zambia Effect of herpes simplex therapy on genital and plasma HIV viral load Maternal health and prevention of mother to child transmission 18-month effectiveness of short-course perinatal antiretroviral regimens combined to infant-feeding interventions for PMTCT in DITRAME PLUS ANRS 1201/1202 2001-2005 HIV prevalence rates amongst 6 week old infants in South Africa: the case for universal screening at immunisation clinics Maternal illness during pregnancy is associated with In utero mother to child transmission Extensively drug resistant TB (XTB) in South Africa Antiretrovirals Early access programme for MK-0518 integrase inhibitor Etravirine (TMC-125) available on named patient programme in the UK Fixed dose combination (FDC) of tenofovir/FTC/efavirenz (Atripla) filed in EU Tipranavir available in Scotland – almost one year after EU approval FDA decision delayed on Biojector for administering T-20 pending additional safety information Treatment access Gilead licenses tenofovir to Indian generic manufacturers Funding prospects improve for Round 6 Global Fund Guidelines BHIVA draft report on UK standards for HIV care (2006) US adult treatment guidelines updated (2006) TB coinfection Extensively drug resistant tuberculosis: a serious wake-up call for global health Global report on TB and HIV: new analysis of TB/HIV epidemics in Bangladesh, Brazil, Nigeria, Tanzania, and Thailand Basic science and immunology Viral load is a poor predictor of CD4 decline at the individual level PDFs Volume 7 Number 10 October 2006 PDF HTB homepage • Conference reports • Articles by subject • Subscribe